Functional epigenetic approach identifies frequently methylated genes in Ewing sarcoma

Abdullah Alholle, Anna T. Brini, Seley Gharanei, Sumathi Vaiyapuri, Elena Arrigoni, Ashraf Dallol, Dean Gentle, Takeshi Kishida, Toru Hiruma, Smadar Avigad, Robert Grimer, Eamonn R. Maher, Farida Latif

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Using a candidate gene approach we recently identified frequent methylation of the RASSF2 gene associated with poor overall survival in Ewing sarcoma (Es). To identify effective biomarkers in Es on a genome-wide scale, we used a functionally proven epigenetic approach, in which gene expression was induced in Es cell lines by treatment with a demethylating agent followed by hybridization onto high density gene expression microarrays. after following a strict selection criterion, 34 genes were selected for expression and methylation analysis in Es cell lines and primary Es. Eight genes (CTHRC1, DNAJA4, ECHDC2, NEFH, NPTX2, P H F 11, RARRES2, TSGA14) showed methylation frequencies of >20% in Es tumors (range 24-71%), these genes were expressed in human bone marrow derived mesenchymal stem cells (hBMsc) and hypermethylation was associated with transcriptional silencing. Methylation of NPTX2 or P H F11 was associated with poorer prognosis in Es. In addition, six of the above genes also showed methylation frequency of >20% (range 36-50%) in osteosarcomas. Identification of these genes may provide insights into bone cancer tumorigenesis and development of epigenetic biomarkers for prognosis and detection of these rare tumor types.

Original languageEnglish
Pages (from-to)1198-1204
Number of pages7
JournalEpigenetics
Volume8
Issue number11
DOIs
Publication statusPublished - 2013

Fingerprint

Ewing's Sarcoma
Epigenomics
Methylation
Genes
Biomarkers
Gene Expression
Cell Line
Bone Neoplasms
Bone Development
Osteosarcoma
Mesenchymal Stromal Cells
Patient Selection
Carcinogenesis
Bone Marrow
Genome
Survival

Keywords

  • 5-aza-2′-deoxycytidine
  • Bone tumors
  • Ewing sarcoma
  • Functional epigenomics
  • Osteosarcoma

ASJC Scopus subject areas

  • Molecular Biology
  • Cancer Research

Cite this

Alholle, A., Brini, A. T., Gharanei, S., Vaiyapuri, S., Arrigoni, E., Dallol, A., ... Latif, F. (2013). Functional epigenetic approach identifies frequently methylated genes in Ewing sarcoma. Epigenetics, 8(11), 1198-1204. https://doi.org/10.4161/epi.26266

Functional epigenetic approach identifies frequently methylated genes in Ewing sarcoma. / Alholle, Abdullah; Brini, Anna T.; Gharanei, Seley; Vaiyapuri, Sumathi; Arrigoni, Elena; Dallol, Ashraf; Gentle, Dean; Kishida, Takeshi; Hiruma, Toru; Avigad, Smadar; Grimer, Robert; Maher, Eamonn R.; Latif, Farida.

In: Epigenetics, Vol. 8, No. 11, 2013, p. 1198-1204.

Research output: Contribution to journalArticle

Alholle, A, Brini, AT, Gharanei, S, Vaiyapuri, S, Arrigoni, E, Dallol, A, Gentle, D, Kishida, T, Hiruma, T, Avigad, S, Grimer, R, Maher, ER & Latif, F 2013, 'Functional epigenetic approach identifies frequently methylated genes in Ewing sarcoma', Epigenetics, vol. 8, no. 11, pp. 1198-1204. https://doi.org/10.4161/epi.26266
Alholle, Abdullah ; Brini, Anna T. ; Gharanei, Seley ; Vaiyapuri, Sumathi ; Arrigoni, Elena ; Dallol, Ashraf ; Gentle, Dean ; Kishida, Takeshi ; Hiruma, Toru ; Avigad, Smadar ; Grimer, Robert ; Maher, Eamonn R. ; Latif, Farida. / Functional epigenetic approach identifies frequently methylated genes in Ewing sarcoma. In: Epigenetics. 2013 ; Vol. 8, No. 11. pp. 1198-1204.
@article{2cc97927e69349f89320bad5f08674d5,
title = "Functional epigenetic approach identifies frequently methylated genes in Ewing sarcoma",
abstract = "Using a candidate gene approach we recently identified frequent methylation of the RASSF2 gene associated with poor overall survival in Ewing sarcoma (Es). To identify effective biomarkers in Es on a genome-wide scale, we used a functionally proven epigenetic approach, in which gene expression was induced in Es cell lines by treatment with a demethylating agent followed by hybridization onto high density gene expression microarrays. after following a strict selection criterion, 34 genes were selected for expression and methylation analysis in Es cell lines and primary Es. Eight genes (CTHRC1, DNAJA4, ECHDC2, NEFH, NPTX2, P H F 11, RARRES2, TSGA14) showed methylation frequencies of >20{\%} in Es tumors (range 24-71{\%}), these genes were expressed in human bone marrow derived mesenchymal stem cells (hBMsc) and hypermethylation was associated with transcriptional silencing. Methylation of NPTX2 or P H F11 was associated with poorer prognosis in Es. In addition, six of the above genes also showed methylation frequency of >20{\%} (range 36-50{\%}) in osteosarcomas. Identification of these genes may provide insights into bone cancer tumorigenesis and development of epigenetic biomarkers for prognosis and detection of these rare tumor types.",
keywords = "5-aza-2′-deoxycytidine, Bone tumors, Ewing sarcoma, Functional epigenomics, Osteosarcoma",
author = "Abdullah Alholle and Brini, {Anna T.} and Seley Gharanei and Sumathi Vaiyapuri and Elena Arrigoni and Ashraf Dallol and Dean Gentle and Takeshi Kishida and Toru Hiruma and Smadar Avigad and Robert Grimer and Maher, {Eamonn R.} and Farida Latif",
year = "2013",
doi = "10.4161/epi.26266",
language = "English",
volume = "8",
pages = "1198--1204",
journal = "Epigenetics",
issn = "1559-2294",
publisher = "Taylor and Francis Inc.",
number = "11",

}

TY - JOUR

T1 - Functional epigenetic approach identifies frequently methylated genes in Ewing sarcoma

AU - Alholle, Abdullah

AU - Brini, Anna T.

AU - Gharanei, Seley

AU - Vaiyapuri, Sumathi

AU - Arrigoni, Elena

AU - Dallol, Ashraf

AU - Gentle, Dean

AU - Kishida, Takeshi

AU - Hiruma, Toru

AU - Avigad, Smadar

AU - Grimer, Robert

AU - Maher, Eamonn R.

AU - Latif, Farida

PY - 2013

Y1 - 2013

N2 - Using a candidate gene approach we recently identified frequent methylation of the RASSF2 gene associated with poor overall survival in Ewing sarcoma (Es). To identify effective biomarkers in Es on a genome-wide scale, we used a functionally proven epigenetic approach, in which gene expression was induced in Es cell lines by treatment with a demethylating agent followed by hybridization onto high density gene expression microarrays. after following a strict selection criterion, 34 genes were selected for expression and methylation analysis in Es cell lines and primary Es. Eight genes (CTHRC1, DNAJA4, ECHDC2, NEFH, NPTX2, P H F 11, RARRES2, TSGA14) showed methylation frequencies of >20% in Es tumors (range 24-71%), these genes were expressed in human bone marrow derived mesenchymal stem cells (hBMsc) and hypermethylation was associated with transcriptional silencing. Methylation of NPTX2 or P H F11 was associated with poorer prognosis in Es. In addition, six of the above genes also showed methylation frequency of >20% (range 36-50%) in osteosarcomas. Identification of these genes may provide insights into bone cancer tumorigenesis and development of epigenetic biomarkers for prognosis and detection of these rare tumor types.

AB - Using a candidate gene approach we recently identified frequent methylation of the RASSF2 gene associated with poor overall survival in Ewing sarcoma (Es). To identify effective biomarkers in Es on a genome-wide scale, we used a functionally proven epigenetic approach, in which gene expression was induced in Es cell lines by treatment with a demethylating agent followed by hybridization onto high density gene expression microarrays. after following a strict selection criterion, 34 genes were selected for expression and methylation analysis in Es cell lines and primary Es. Eight genes (CTHRC1, DNAJA4, ECHDC2, NEFH, NPTX2, P H F 11, RARRES2, TSGA14) showed methylation frequencies of >20% in Es tumors (range 24-71%), these genes were expressed in human bone marrow derived mesenchymal stem cells (hBMsc) and hypermethylation was associated with transcriptional silencing. Methylation of NPTX2 or P H F11 was associated with poorer prognosis in Es. In addition, six of the above genes also showed methylation frequency of >20% (range 36-50%) in osteosarcomas. Identification of these genes may provide insights into bone cancer tumorigenesis and development of epigenetic biomarkers for prognosis and detection of these rare tumor types.

KW - 5-aza-2′-deoxycytidine

KW - Bone tumors

KW - Ewing sarcoma

KW - Functional epigenomics

KW - Osteosarcoma

UR - http://www.scopus.com/inward/record.url?scp=84887444200&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84887444200&partnerID=8YFLogxK

U2 - 10.4161/epi.26266

DO - 10.4161/epi.26266

M3 - Article

C2 - 24005033

AN - SCOPUS:84887444200

VL - 8

SP - 1198

EP - 1204

JO - Epigenetics

JF - Epigenetics

SN - 1559-2294

IS - 11

ER -